M Kew
Overview
Explore the profile of M Kew including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jennewine B, Fiorino D, Kew M, Byrne A, Yarboro S
Injury
. 2019 Aug;
50(11):2093-2096.
PMID: 31383354
Introduction: Common practice in orthopedic surgery is to obtain postoperative radiographs to evaluate for healing or complications. Images obtained in the post-anesthesia care unit (PACU) have not been shown to...
2.
Alam U, Najam O, Al-Himdani S, Benoliel S, Jinadev P, Berry J, et al.
Diabet Med
. 2012 Apr;
29(10):1343-5.
PMID: 22507464
No abstract available.
3.
Liu J, Lian Z, Han S, Waye M, Wang H, Wu M, et al.
Oncogene
. 2005 Oct;
25(7):1008-17.
PMID: 16247464
Hepatitis B virus (HBV)-encoded X antigen (HBxAg) contributes to the development of hepatocellular carcinoma (HCC). A frequent characteristic of HCC is reduced or absent expression of the cell adhesion protein,...
4.
Kew M, Francois G, Lavanchy D, Margolis H, Van Damme P, Grob P, et al.
J Viral Hepat
. 2004 May;
11(3):198-205.
PMID: 15117321
In spite of advances made in our understanding of the biology of the hepatitis C virus (HCV), the epidemiology and natural history of HCV infection, and the treatment of chronic...
5.
Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, et al.
Cancer Res
. 2001 Nov;
61(21):7803-10.
PMID: 11691796
The hepatitis B virus (HBV) X protein (HBx) is a transcriptional transactivator that has been implicated in the development of HBV-related hepatocellular carcinoma. Mutations in the HBx open reading frame...
6.
Schwarz K, Kew M, Klein A, Abrams R, Sitzmann J, Jones L, et al.
Dig Dis Sci
. 2001 Oct;
46(10):2173-8.
PMID: 11680593
Since oxidative DNA damage plays a role in experimental carcinogen-induced cancers, the purpose of the present study was to determine if hepatic oxidative DNA damage was increased in patients with...
7.
Arbuthnot P, Kew M
Int J Exp Pathol
. 2001 Jul;
82(2):77-100.
PMID: 11454100
Chronic hepatitis B virus (HBV) infection is a major global cause of hepatocellular carcinoma (HCC). Individuals who are chronic carriers have a greater than 100-fold increased relative risk of developing...
8.
Lian Z, Liu J, Pan J, Satiroglu Tufan N, Zhu M, Arbuthnot P, et al.
Hepatology
. 2001 Jun;
34(1):146-57.
PMID: 11431746
Polymerase chain reaction (PCR) select complementary DNA (cDNA) subtraction of hepatitis B x antigen (HBxAg)-positive compared with -negative HepG2 cells resulted in the up-regulated expression of a cellular gene that...
9.
Francois G, Kew M, Van Damme P, Mphahlele M, Meheus A
Vaccine
. 2001 Jun;
19(28-29):3799-815.
PMID: 11427251
No abstract available.
10.
Weinberg M, Passman M, Kew M, Arbuthnot P
J Hepatol
. 2000 Jul;
33(1):142-51.
PMID: 10905598
Background/aims: Chronic infection with hepatitis B virus (HBV) is endemic to sub-Saharan Africa and parts of Asia. Common complications of HBV persistence include cirrhosis and hepatocellular carcinoma (HCC). Present treatment...